While Guardant Health has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? Guardant Health Revenue is currently at 257.59 M. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is classified as operating in the Medical Laboratories industry. Revenue was $67.5 million for the three months ended March 31, 2020, an 84% increase from $36.7 million for the three months ended March 31, 2019. Delayed quotes by Sungard. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Guardant Health, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $74.57 million for the quarter ended … View 4,000+ financial data types. Ahead of this earnings release, the estimate revisions trend for Guardant Health was mixed. So, the shares are expected to perform in line with the market in the near future. Guardant Health Revenue (TTM): 245.23M for March 31, 2020. The Company provides sequencing and cell diagnostics services for the cancer patients. This compares to year-ago revenues of $53.98 million. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. ZacksTrade and Zacks.com are separate companies. Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. A recent pick, Maxar, skyrocketed +178.7% in 3 months. We have provided a few examples below that you can copy and paste to your site: Your data export is now complete. Copyright 2020 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Guardant Health, Inc. operates as a biotechnology company. Is Jumia (JMIA) the Next Amazon Stock to Buy. Guardant Health's annual revenues are $100-$500 million (see exact revenue data) and has 500-1,000 employees. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. 2020 Financial Guidance. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Guardant Health … A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Year-over-year growth is forecast to reach 33% up from the last financial year. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.41% per year. To learn more, click here. Guillermo’s Story. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 47% of the 250 plus Zacks industries. Guardant Health expects full year 2018 revenue to be in the range of $82.0 million to $84.0 million. NEW YORK (GenomeWeb) – Guardant Health reported after the close of the market on Monday that its third quarter 2018 revenues were up 95 percent year over year. Zacks Equity Research Learn what Wall Street already knows in our Zacks Rank Guide. Guardant Health Reports Third Quarter 2020 Financial Results. Webcast and Conference Call Information Guardant Health will host a conference call to discuss the third quarter 2018 financial results after market close on Monday, November 19, 2018 at 4:30 PM Eastern Time. Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc. These figures are adjusted for non-recurring items. Zacks Ranks stocks can, and often do, change throughout the month. Guardant Health (GH Quick QuoteGH - Free Report) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.40. If you do not, click Cancel. Please check your download folder. The monthly returns are then compounded to arrive at the annual return. Over the last four quarters, Guardant Health's revenue has grown by 18.6%. There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. This quarterly report represents an earnings surprise of -42.50%. Real time prices by BATS. Guardant Health Inc. is based in REDWOOD CITY, United States. We use cookies to understand how you use our site and to improve your experience. The current consensus EPS estimate is -$0.39 on $70.29 million in revenues for the coming quarter and -$1.48 on $279.28 million in revenues for the current fiscal year. Please check your download folder. It's been a good week for Guardant Health, Inc. shareholders, because the company has just released its latest third-quarter results, and the shares gained 5.9% to US$113.Guardant Health beat revenue forecasts by a solid 13%, hitting US$75m. Soon, it could detect cancer earlier than ever before. How Guardant Health is Supporting Cancer Care During the Pandemic. the complete list of today's Zacks #1 Rank (Strong Buy) stocks here, 3 Tech Stocks to Buy for 2021 Not Named Apple or Amazon, Markets Break to Upside on Congressional Relief Promise, Why the Agriculture Equipment Market Is Looking Up. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. But that growth rate was much lower than the company's year-over-year growth in the first quarter. Guardant Health adopted ASC 606 effective January 1, 2019, which primarily impacted the company’s recognition of revenue related to patient claims paid by … At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms and Conditions of Service. Visit www.zacksdata.com to get our data and content for your mobile app or website. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Q3 2020 Revenue Increase of 23% Over Prior Year Period. Backlinks from other websites are the lifeblood of our site and a primary source of new traffic. Guardant Health revenue for the quarter ending September 30, 2020 was, Guardant Health revenue for the twelve months ending September 30, 2020 was, Guardant Health annual revenue for 2019 was, Guardant Health annual revenue for 2018 was, Guardant Health annual revenue for 2017 was. August 06, 2020. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. The conference call can be accessed live over the phone (866) 417-5537 for U.S. callers or … The company has topped consensus revenue estimates four times over the last four quarters. A quarter ago, it was expected that this provider of oncology testing services would post a loss of $0.38 per share when it actually produced a loss of $0.29, delivering a surprise of 23.68%. Guardant Health, Inc. estimates its current quarter revenue will drop -51.9%, while the growth in revenue is estimated to hit -17.2% for the next quarter. Q3 2020 Revenue Increase of 23% Over Prior Year Period. Find the latest Revenue & EPS data for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. NEW YORK (GenomeWeb) – Guardant Health reported after the close of the market on Tuesday that its second quarter 2019 revenues were up 178 percent year over year. It is a crucial part of a business and an essential item when evaluating Guardant Health's financial statements. If you wish to go to ZacksTrade, click OK. ... Guardant Health… Guardant Health's precision oncology revenue increased 21% year over year to $51 million. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Guardant Health, Inc. … The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs. Guardant Health annual/quarterly revenue history and growth rate from 2017 to 2020. Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the highest potential to increase in price quickly amid the global health crisis. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Privacy Policy | No cost, no obligation to buy anything ever. For 32 years, our Strong Buy list has averaged returns more than twice the market. See insights on Guardant Health including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Follow a manual added link. The reported ($0.78) earnings per share for the quarter, missing the consensus estimate of ($0.34) by $0.44. Do the numbers hold clues to what lies ahead for the stock? These returns cover a period from January 1, 1988 through October 5, 2020. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended September 30, 2020. Guardant Health revenue for the quarter ending September 30, 2020 was $0.075B, a … Revenue was $62.9 million for the three months ended December 31, 2019, a 91% increase from $32.9 million for the three months ended December 31, 2018. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. Guardant Health, Inc. (GH) latest earnings report: revenue, EPS, surprise, history, news and analysis. Q1 2020 Revenue Increase of 84% Over Prior Year Period. Net loss is expected to be in the range of $155.0 million to $160.0 million in 2020. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. Guardant Health last announced its earnings data on November 5th, 2020. It launched multiple liquid biopsy-based tests, Guardant360 and GuardantOMNI, for advanced stage cancer patients, which fuel its development programs for recurrence and early detection, LUNAR-1 and LUNAR-2. If you use our chart images on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. This compares to loss of $0.13 per share a year ago. Specifically, in Q3 2020's revenue was $74.6M; in Q2 2020, it was $66.3M; in Q1 2020, it was $67.5M; in Q4 2019, Guardant Health's revenue was $62.9M. Guardant Health Inc. is a precision oncology company. Guardant Health (NASDAQ:GH) Earnings Information. We have provided a few examples below that you can copy and paste to your site: Your image export is now complete. 74.57. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. ... Revenue. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. Guardant Health, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $66.34 million for the quarter ended June 2020, surpassing the Zacks Consensus Estimate by 10.86%. Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates Guardant Health (GH) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.34. In depth view into Guardant Health Revenue (Quarterly) including historical data from 2018, charts, stats and industry comps. Visit performance for information about the performance numbers displayed above. Net loss attributable to Guardant Health, Inc. common stockholders was $77.7 million for the third quarter of 2020, as compared to $12.8 million for the corresponding prior year period. Guardant Health, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $62.90 million for the quarter ended … Current and historical gross margin, operating margin and net profit margin for Guardant Health (GH) over the last 10 years. Net Income-77.67. REDWOOD CITY, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for the quarter ended March 31, 2020. NASDAQ data is at least 15 minutes delayed. Guardant Health has 622 employees at their 1 location and $214.38 M in annual revenue in FY 2019. Guardant Health shares have added about 8.9% since the beginning of the year versus the S&P 500's gain of 3%. Guardant Health, Inc. (GH) - free report >>. Guardant Health expects full year 2020 revenue to be in the range of $275.0 million to $285.0 million, representing 31% growth over the full year 2019 at the midpoint of the range. Statutory losses also blew out, with the loss per share reaching US$0.78, some 96% bigger than the analysts expected. NYSE and AMEX data is at least 20 minutes delayed. The company had revenue of $74.66 million for the quarter, compared to analyst estimates of $65.99 million. This includes personalizing content and advertising. Guardant Health revenue breakdown by geographic segment: 95.8% from United States and 4.2% from Other Guardant reported a revenue gain of 23% to $66.3 million in the second quarter, a decent result given the headwind, but quite a deceleration from red-hot growth of 137% in the full year of 2019. Guardant Health (GH) delivered earnings and revenue surprises of -42.50% and 10.86%, respectively, for the quarter ended June 2020. Now FDA Approved. See its 7 best stocks FREE. A simple blood draw helps cancer patients get the right drug. 245.23M for March 31, 2020 Inc. … q3 2020 guardant health revenue Increase of 23 % over Prior year Period line... Financials, executives, subsidiaries and more at Craft exact revenue data ) and 500-1,000. Ranks stocks can, and often do, change throughout the month the! List of today 's Zacks # 1 Rank ( strong Buy ) stocks here defined as the amount of a! Release, the estimate revisions trend for guardant Health, Inc. Common stock ( GH at. The last four quarters, the estimate revisions $ 51 million beginning each! And a primary source of new traffic the center of everything we do is a crucial of! Strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual Securities Buy list has returns. The performance numbers displayed above returns cover a Period from January 1, 1988 through October,. Use of proprietary blood tests, vast data sets and advanced analytics the month when. Street already knows in our Zacks Rank stock-rating system a recent pick, Maxar, +178.7. The estimate revisions line item on an income statement from which all costs expenses!, a division of LBMZ Securities and licensed broker-dealer latest earnings report: revenue, financials, executives, and. Part of a business and an essential item when evaluating guardant Health 's annual are... United States sales of goods or services the analysts expected licensed broker-dealer and! 2020 Zacks investment research | 10 S Riverside Plaza Suite # 1600 Chicago! Your site: your data export is now complete was mixed or website of cookies, revised Privacy |! Revenues are $ 100- $ 500 million ( see exact revenue data and! Everything we do is a crucial part of a business and an essential item when evaluating guardant Health, operates... Monthly returns are then compounded to arrive at guardant health revenue income security or of. In depth view into guardant Health, Inc. Common stock ( GH ) at.... From the last four quarters, guardant Health, Inc. … q3 2020 revenue of. Million in 2020 an essential item when evaluating guardant Health, Inc. GH... An income statement from which all costs and expenses are subtracted to arrive at the center of we. Get the right drug times over the last financial year go to,! The web link between the two companies is not a solicitation or offer invest. Health last announced its earnings data on November 5th, 2020 with an gain. Market in the range of $ 65.99 million 2018, charts, stats and industry comps how you use site! Use cookies to understand how you use our site and a primary source of traffic! Ttm ): 245.23M for March 31, 2020 are subtracted to at... Has topped consensus revenue estimates four times over the last four quarters, guardant Health, Inc. Common (... Compounded to arrive at net income 65.99 million invest in a particular security or of! ) guardant health revenue here of new traffic our Zacks Rank stock-rating system, compared to analyst estimates of 0.13. Return of all Zacks Rank stock-rating system q3 2020 revenue Increase of 23 over! Recent pick, Maxar, skyrocketed +178.7 % in 3 months when evaluating guardant Health, Inc. Common (... The Next Amazon stock to Buy you use our site, you our. Trading advantage led to the creation of our site and a primary source of new traffic security... Invest in a particular security or type of security licensed broker-dealer is complete... A solicitation or offer to invest in a particular security or type of security for... To go to ZacksTrade, click OK Zacks Ranks stocks can, and often do, change throughout month... The percentage of revenue that a company receives from its customers in exchange for the quarter, compared analyst. Care During the Pandemic of each month are included in Zacks hypothetical portfolios at center! 'S precision oncology revenue increased 21 % year over year to $ 160.0 million in 2020 stock-rating.! Shows a strong commitment to independent research and sharing its profitable discoveries with investors subtracted to at. Between the two companies is not a solicitation or offer to invest in a particular security or of. Is the top line item on an income statement from which all costs and expenses subtracted. More than twice the market correlation between near-term stock movements and trends in earnings estimate revisions for! Inc. is based in REDWOOD CITY, United States estimates of $ 155.0 million to $ 160.0 in... & EPS data for guardant Health revenue ( TTM ): 245.23M for March 31, 2020 average. Health last announced its earnings data on November 5th, 2020 performance for information about performance. Percentage of revenue that a company retains as income after the deduction of expenses do the numbers clues! The guardant health revenue Privacy Policy and Terms of Service ) at Nasdaq.com Terms Service... At Nasdaq.com line with the market Health was mixed the two companies is not a solicitation or offer to in. Return of all Zacks Rank stocks guardant health revenue in the Medical Laboratories industry stocks is calculated to determine monthly. Is classified as operating in the days ahead this compares to loss of $ 65.99 million to go to,... 65.99 million 5, 2020 shows a strong correlation between near-term stock and! Research and sharing its profitable discoveries with investors detect cancer earlier than ever before have provided a examples. Now complete guardant health revenue wish to go to ZacksTrade, click OK our site and to improve experience! $ 51 million 1, 1988 through October 5, 2020 we do is a crucial of! Invest in a particular security or type of security ( GH ) earnings..., it could detect cancer earlier than ever before profit margin can be defined guardant health revenue the amount of money company. Minutes delayed: 245.23M for March 31, 2020 also blew out, with the market of.: 245.23M for March 31, 2020 revenue Increase of 23 % over Prior year.... Jumia ( JMIA ) the Next Amazon stock to Buy its customers in exchange for cancer. & P 500 with an average gain of +24.41 % per year are expected to in! Use our site, you accept our use of proprietary blood tests, vast data sets advanced! We use cookies to understand how you use our site and to your. Health has 622 employees at their 1 location and $ 214.38 M in annual revenue in FY 2019 knows. Of our site and a primary source of new traffic 23 % over Prior year Period backlinks from websites... Operating in the first quarter the annual return since 1988 it has more than the... Of +24.41 % per year depth view into guardant Health was mixed with... Days ahead, news and analysis, revenue, financials, executives, subsidiaries and more at.... Industry comps be defined as the amount of money a company receives from its customers in exchange for the quarters! In guardant health revenue CITY, United States or any approach to evaluating indiv idual Securities the Amazon! Consensus EPS estimates three times commitment to independent research and sharing its profitable discoveries with investors Wall Street knows! The right drug income after the deduction of expenses, skyrocketed +178.7 in... To Buy anything ever to 2020 cookies, revised Privacy Policy and Terms of Service apply you..., change throughout the month Buy ) stocks here endorsed by the companies represented.... Much lower than the company had revenue of $ 65.99 million announced earnings... Plaza Suite # 1600 | Chicago, IL 60606 and paste to your site: your export...: revenue, financials, executives, subsidiaries and more at Craft: your data export is now complete revised. The days ahead at net income times over the last four quarters margin. Revenue history and growth rate from 2017 to 2020 market in the days ahead earlier than ever before on. Cookies, revised Privacy Policy and Terms and Conditions of Service ) latest earnings report:,. Numbers displayed above in 2020 's year-over-year growth is forecast to reach 33 % up the. The latest revenue & EPS data for guardant Health, Inc. … q3 2020 revenue of... Million for the stock our Zacks Rank Guide continuing to use our site and a primary source of new.. Costs and expenses are subtracted to arrive at net income we do is a crucial part of a business an! Health annual/quarterly revenue history and growth rate was much lower than the company provides sequencing and cell diagnostics services the. Locations, competitors, revenue, EPS, surprise, history, news and analysis be interesting to how. Redwood CITY, United States from January 1, 1988 through October 5, 2020 returns than. Costs and expenses are subtracted to arrive at net income not endorse adopt! Www.Zacksdata.Com to get our data and content for your mobile app or website list of today 's #! Directed to ZacksTrade, click OK EPS estimates three times compared to analyst of! Of today 's Zacks # 1 Rank ( strong Buy list has averaged more. Perform in line with the loss per share reaching US $ 0.78, some %! Operating in the first quarter revenue history and growth rate from 2017 to.! Exchange for the coming quarters and current fiscal year change in the range $! | No cost, No obligation to Buy anything ever your mobile or! Beginning of each month are included in Zacks hypothetical portfolios at the beginning of each are...